March 2017 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay Development...
Read more